Company / Current Assets per Share
Aurinia Pharmaceuticals Inc. Current Assets per Share History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets per Share
$3.49
FY2025
5-year range
$3.00 / $4.59
FY2021-FY2025
Trend
+12.5%
vs FY2024
Sector context
#154 of 210
Health Care
What the data says
At $3.49, Aurinia Pharmaceuticals Inc.'s current assets per share ranks #154 of 210 in the Health Care sector. Improved from $3.00 to $3.49 over the past 2 years.
Based on SEC 10-K filings.
3.49 in FY2025 with a 5-year CAGR of -6.6%.
Improved from $3.00 to $3.49 over the past 2 years.
Health Care sector context is included.
Current Assets per Share over time
Growth rates
- 3-Year CAGR
- -0.0%
- 5-Year CAGR
- -6.6%
- 10-Year CAGR
- -
Sector benchmark
#154 of 210 in Health CareTop 73% of 210This company $3.49 Sector average $134.38
▼
-97.4% below sector average
Key checks
Key Insights
- In FY2025, current assets per share increased 12.5% year-over-year.
- Ranks #154 out of 210 companies in the Health Care sector.
- Peak current assets per share was recorded in FY2020.
- Lowest current assets per share in the period was in FY2023.
Company context
Key Data Points
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $3.49 | +12.5% |
| FY2024 | $3.10 | +3.5% |
| FY2023 | $3.00 | -14.1% |
| FY2022 | $3.49 | -23.9% |
| FY2021 | $4.59 | -6.4% |
| FY2020 | $4.91 | +44.8% |
| FY2019 | $3.39 | - |
| FY2018 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026